At the interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in overall survival (OS), one of the study’s dual primary endpoints, compared to the control arm of either abiraterone acetate or enzalutamide
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
The expansion reiterates BASF’s continued commitment to Asia Pacific and specifically to customers in the medical glove industry
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors
First PARP inhibitor to demonstrate overall survival benefit in early breast cancer
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation
Subscribe To Our Newsletter & Stay Updated
